Team Europe contributes €500 million to COVAX initiative

The European Investment Bank has approved €400 million of financing to support the participation of low and middle income economies in COVAX Advance Market Commitment (COVAX AMC).

Fair and equitable access to a successful COVID-19 vaccine, regardless of income, for millions of people across Africa, Asia, the Caribbean and Pacific, and in Europe’s eastern and southern neighbourhood, has been enabled by the new European financial support for the global vaccine initiative COVAX. Team Europe’s engagement will accelerate global efforts to bring the pandemic under control and scale up distribution of a successful vaccine as soon as it becomes available.

Covax initiative
New European Union financing for COVAX will secure access to safe and effective COVID-19 vaccines for high-risk and vulnerable populations alongside front-line health workers in low and middle income countries

Safe and effective COVID-19 vaccines

This rapidly approved financing, guaranteed by the European Fund for Sustainable Development and alongside €100 million grant support from the European Commission to COVAX AMC, will support access to safe and effective COVID-19 vaccines in 92 low and middle-income countries.

This enables COVAX, a multilateral initiative aimed at ensuring global fair and equitable access, to accelerate up-front investment essential to deliver vaccine doses as soon as they become available.

“This vital funding from the European Commission and the European Investment Bank ensures that lower income economies are not left behind when a safe and effective COVID-19 vaccine is available. Team Europe’s support will play a vital role in ending the acute phase of this pandemic,” says Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance. “This funding is a tremendous boost as we look to raise at least an additional US$ 5 billion in 2021 to ensure equitable distribution of these vaccines to all those who need them.”

“The European Commission and the European Investment Bank are strong supporters of COVAX, the world’s facility to ensure fair and universal access to COVID-19 vaccines. Together with the EU Member States, Team Europe has so far allocated more than €850 million to COVAX, which makes the European Union COVAX’s biggest donor. The European Commission and EIB’s combined support of €500 million will enable COVAX to make one billion doses of vaccines available as rapidly as possible to people in low and middle income countries,” says the president of the European Commission, Ursula von der Leyen.

“It is a moral imperative that no country should be excluded from access to COVID-19 vaccines because of costs. The European Investment Bank’s €400 million support for COVAX is a response to this by helping ensure fair access to successful COVID-19 vaccines. Through this new loan the EIB is strengthening Team Europe’s partnership with COVAX and accelerating an effective response to end the global pandemic. Since the start of the COVID pandemic the EIB has been working with partners across Europe and around the world to accelerate vaccine development, strengthen public health and help business weather the crisis, with more than €27 billion of COVID related financing approved in recent months. The success of several vaccine programmes, notably BioNTech’s, backed by the European Commission and European Investment Bank, is giving the world hope that a recovery is closer. The time has now come to look ahead and ensure that all countries can benefit from this progress,” says President of the European Investment Bank Werner Hoyer.

Jutta Urpilainen, commissioner for International Partnerships, adds: “By working together, Team Europe and its partners help to make the vaccine a global public good to help end the pandemic, ensure a sustainable recovery, and build back better. EU’s €100 million grant and the €400 million EIB loan, backed by the EFSD guarantee, will support access, to COVID-19 vaccines in low and middle-income countries”.

Prioritising vaccine provision to high-risk groups and front-line services

New European Union financing for COVAX will secure access to safe and effective COVID-19 vaccines for high-risk and vulnerable populations alongside front-line health workers in low and middle income countries at the same time as vaccines are procured for self-financing economies, including the European Union.

Ensuring global roll out of successful COVID-19 vaccine

The new €500 million European support for COVAX AMC will help COVAX reserve and accelerate doses for 92 low and middle income economies. Agreements between the European Union and partner countries across Africa, Asia, the Caribbean and Pacific, as well as the eastern and southern neighbourhood, already exist under the European Fund for Sustainable Development.

Vaccines will be procured and delivered by UNICEF and the Pan-American Health Organisation (PAHO) on behalf of COVAX.   



Latest


22 Jan 2021
Clere celebrates 60 years of spreading the love for skin

This year heritage skin care brand, Clere is celebrating its 60th anniversary. “The name Clere has been synonymous with soft,…

Clere celebrates 60 years of spreading the love for skin

This year heritage skin care brand, Clere is celebrating its 60th anniversary. “The name Clere has been synonymous with soft, smooth, beautiful looking skin for six decades now. It’s a favourite in both South African homes and those abroad. Over the years Clere has managed to remain relevant, and up…

21 Jan 2021
COVID-19 vaccine – how will Africa keep it cold enough?

While we await the first vaccines to either arrive in the country via air, or under licence from local manufactured…

COVID-19 vaccine – how will Africa keep it cold enough?

While we await the first vaccines to either arrive in the country via air, or under licence from local manufactured sources, there remains another obstacle. The so-called cold supply chain that needs to remain intact when delivering the COVID-19 vaccine to all corners of the country. The temperatures needed for…

18 Jan 2021
Solvay commits to sustainable cyclopentanone production

Solvay has begun a process of decarbonising the cyclopentanone unit of its Melle plant in France. Through an agreement with…

Solvay commits to sustainable cyclopentanone production

Solvay has begun a process of decarbonising the cyclopentanone unit of its Melle plant in France. Through an agreement with an agricultural cooperative for the next 15 years, the entire cyclopentanone production will indeed rely solely on biomethane gas, a green source of energy. The cooperative built a facility to…

18 Jan 2021
Irene Cantos becomes IMCD’s group director Personal Care

IMCD has appointed Irene Cantos as business group director Personal Care, effective 6 January 2021. In her role, Cantos, will…

Irene Cantos becomes IMCD’s group director Personal Care

IMCD has appointed Irene Cantos as business group director Personal Care, effective 6 January 2021. In her role, Cantos, will lead the Business Group Personal Care in becoming the global player of choice for both suppliers and customers in the distribution of speciality ingredients. The group aims to grow both…


Top stories


25 Jun 2020
How to ensure business agility in a pandemic

BY: Neil Birch, CEO at Novus Holdings Business agility is the capability of a business to respond quickly to a…

How to ensure business agility in a pandemic

BY: Neil Birch, CEO at Novus Holdings Business agility is the capability of a business to respond quickly to a changing environment, whether it be internal or external. Qualities of agile businesses include being adaptive, flexible and creative in your response to change without losing momentum (remaining productive) or vision.…

01 May 2020
Fibertex manufactures critical components for COVID-19 PPE

Fibertex SA, part of the global Fibertex Nonwovens group, has developed versatile high-performance components for protective facemasks and respirators. “Fibertex,…

Fibertex manufactures critical components for COVID-19 PPE

Fibertex SA, part of the global Fibertex Nonwovens group, has developed versatile high-performance components for protective facemasks and respirators. “Fibertex, which continuously invests in technological advancements to meet requirements in diverse industries – has increased production capacity of materials so desperately needed during the global COVID-19 pandemic,” explains Rosa Naidoo,…

23 Apr 2020
Are you South Africa’s best female entrepreneur?

Entries are now open for the Santam Women of the Future Awards 2020 in association with Fairlady and True Love.…

Are you South Africa’s best female entrepreneur?

Entries are now open for the Santam Women of the Future Awards 2020 in association with Fairlady and True Love. Santam, Fairlady and, for the first time this year, Truelove Magazine, have partnered up in the search to find the best female entrepreneurs in the country. Best women entrepreneurs If…

30 Nov 2017
Rooibos could reduce risk of “Type 3” diabetes – a precursor to Alzheimer’s

Researchers at Warren Alpert Medical School at Brown University in the US found a link between a relatively new form…

Rooibos could reduce risk of “Type 3” diabetes – a precursor to Alzheimer’s

Researchers at Warren Alpert Medical School at Brown University in the US found a link between a relatively new form of diabetes, known as “type 3” diabetes and Alzheimer’s disease.


Visit the official COVID-19 government website to stay informed: sacoronavirus.co.za